Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

ZS Pharma (Forth Worth, TX), a clinical-stage pharmaceutical company focused on the development of therapies to treat kidney and liver disease, closed a $46M Series C. Participants include Alta Partners, RiverVest Venture Partners, 3×5 Special Opportunity Partners, Salem Partners and Devon Park Bioventures. Collective IP | The Most Comprehensive and Accurate View of Global Innovation and […]

Spinal Restoration (Austin, TX), a clinical stage biotechnology company focused on the treatment of discogenic chronic low back pain, closed a $5M Series C financing. Participants include Austin Ventures, Santé Ventures, MB Venture Partners and Comerica Bank. ___________ Collective IP the Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer […]

BiO2 Medical (San Antonio, TX) a clinical-stage medical device company focused on catheters for pulmonary embolism in critical care patients, closed a $13.7M Series B financing. Participants include Incyte Capital and Pasadera Capital.

Leonardo Biosystems (Houston, TX) a development-stage biopharmaceutical company focused on drug delivery technology, closed a $1.25M Series A financing, bringing the total round to $2.5M. Participants include Texas Emerging Technology Fund.

Inova Labs (Austin, TX) a medical device company focused on the development, manufacturing, and worldwide distribution of medical devices used to treat Chronic Obstructive Pulmonary Disease, closed a $17.5 million in Series B financing. Participants include Latterell Venture Partners, Gilde Healthcare Partners and Three Arch Partners.

Affinium Pharmaceuticals (Austin, TX) a clinical-stage specialty pharmaceutical company focused on small molecule antibiotics targeting staph and MRSA infections, closed a $15M Series B financing. Participants include SV Life Sciences, Genesis Capital Partners, Forward Ventures and Ontario Emerging Technologies Fund. Thanx for your patience as we catch-up.

Teladoc (Dallas, TX) a commercial-stage on-demand telehealth services provider, closed a $18.6M Series D financing. Participants include Kleiner Perkins, Cardinal Partners, HLM Venture Partners, Trident Capital and New Capital Partners.

ViroXis (San Antonio, TX) a development stage biopharmaceutical company focused on antiviral treatment of HPV associated skin warts, closed a $2.5M Series A financing. Participants include Texas Emerging Technology Fund.

IDEV Technologies (Webster, TX) a clinical-stage medical device company focused on endovascular and interventional stents, closed a $46M Series D financing. Participants include Piper Jaffray, PTV Sciences, Bay City Capital, RiverVest Venture Partners and Heron Capital.

Ortho Kinematics (Austin, TX) development-stage medical device spine diagnostics company focused on inter-vertebral motion analysis, closed a $2M Series B financing. Participants include Texo Ventures, PTV Sciences and Gatebridge Investments.

Reata Pharmaceuticals (Irving, TX) a clinical-stage small molecule company focused on inflammation modulation in chronic kidney disease, closed a $78M Series D financing. Participants include CPMG and Novo Ventures.

Ensysce Biosciences (Houston, TX) a development-stage biopharma company focused on carbon nanotube complexes for chemotherapeutic transport, closed a $1.5M Series A financing. Participants include Texas Emerging Technology Fund.

Palmaz Scientific (Dallas, TX) a development-stage nano-biomaterials company focused on a vapor deposition process to increase the reliability of implantable prosthetic devices, closed a $3M Series A financing. Participants include Texas Emerging Technology Fund.

« Previous Entries  Next Page »

to top of page...